Last edition
News about "ADVANZ PHARMA"
Alvotech Announces European Launch of Golimumab Biosimilar via Advanz Pharma
Alvotech has announced the European launch of AVT05, the first biosimilar to Simponi (golimumab), through its partner Advanz Pharma, following a tender award from NHS England in the UK to support market introduction.
Advanz Pharma | 22/12/2025 | By News Bureau
Alvotech and Advanz Pharma Secure European Approval for Eylea Biosimilar Mynzepli
Alvotech and its commercial partner Advanz Pharma have announced that the European Commission has granted marketing authorisation for Mynzepli (aflibercept), a biosimilar to Eylea, available in both pre-filled syringes and vials.
Advanz Pharma | 22/08/2025 | By Dineshwori | 147
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Advanz Pharma a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced that through its wholly-owned subsidiary, the Company has entered into an arrangement agreement dated March 15, 2020
ADVANZ PHARMA | 17/03/2020 | By Darshana | 462
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy